Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis
Long COVID is a condition distinguished by long-term sequelae that occur or persist after the convalescence period of COVID-19. During the COVID-19 pandemic, more and more people who tested positive for SARS-CoV-2 experienced long COVID, which attracted the attention of researchers. This study aims...
Gespeichert in:
Veröffentlicht in: | International journal of environmental research and public health 2022-03, Vol.19 (6), p.3742 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 6 |
container_start_page | 3742 |
container_title | International journal of environmental research and public health |
container_volume | 19 |
creator | Jin, Hongxia Lu, Lu Fan, Haojun |
description | Long COVID is a condition distinguished by long-term sequelae that occur or persist after the convalescence period of COVID-19. During the COVID-19 pandemic, more and more people who tested positive for SARS-CoV-2 experienced long COVID, which attracted the attention of researchers. This study aims to assess the pattern of long COVID research literature, analyze the research topics, and provide insights on long COVID. In this study, we extracted 784 publications from Scopus in the field of long COVID. According to bibliometric analysis, it is found that: developed countries in Europe and America were in leading positions in terms of paper productivity and citations. The
and the
were leading journals in the perspective of publications count, and
had the highest number of citations. Author Greenhalgh T has the highest number of papers and citations. The main research topics were: pathophysiology, symptoms, treatment, and epidemiology. The causes of long COVID may be related to organ injury, inflammation, maladaptation of the angiotensin-converting enzyme 2 (ACE2) pathway, and mental factors. The symptoms are varied, including physical and psychological symptoms. Treatment options vary from person to person. Most patients developed at least one long-term symptom. Finally, we presented some possible research opportunities. |
doi_str_mv | 10.3390/ijerph19063742 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8955790</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2644012639</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-bcdd485c5e72295c7d6c2b88c1c20662822731b0891e97713f563c3cb84dc03</originalsourceid><addsrcrecordid>eNpdkc1LAzEQxYMotlavHiXgxctqvjfxINSqrVIoqHgN2WxqU7abmmyF_veutop6GGZgfvOYxwPgGKNzShW68HMXlzOskKA5Izugi4VAGRMI7_6aO-AgpTlCVDKh9kGHckoUI7ILHoZVKEwFn6OrywRNXcJHl5yJdgZHoUnLtqCv4TjUr3Awebm_uYR9eO2LyoeFa6K3sF-bap18OgR7U1Mld7TtPfB0d_s8GGXjyfB-0B9nlmHZZIUtSya55S4nRHGbl8KSQkqLLUFCEElITnGBpMJO5TmmUy6opbaQrLSI9sDVRnW5KhautK5uoqn0MvqFiWsdjNd_N7Wf6dfwrqXiPFefAmdbgRjeVi41euGTdVVlahdWSRPBGMJEUNWip__QeVjF1u4XRRjnQrKWOt9QNoaUopv-PIOR_gxJ_w2pPTj5beEH_06FfgCSbYza</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2642455684</pqid></control><display><type>article</type><title>Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>PubMed Central Open Access</source><creator>Jin, Hongxia ; Lu, Lu ; Fan, Haojun</creator><creatorcontrib>Jin, Hongxia ; Lu, Lu ; Fan, Haojun</creatorcontrib><description>Long COVID is a condition distinguished by long-term sequelae that occur or persist after the convalescence period of COVID-19. During the COVID-19 pandemic, more and more people who tested positive for SARS-CoV-2 experienced long COVID, which attracted the attention of researchers. This study aims to assess the pattern of long COVID research literature, analyze the research topics, and provide insights on long COVID. In this study, we extracted 784 publications from Scopus in the field of long COVID. According to bibliometric analysis, it is found that: developed countries in Europe and America were in leading positions in terms of paper productivity and citations. The
and the
were leading journals in the perspective of publications count, and
had the highest number of citations. Author Greenhalgh T has the highest number of papers and citations. The main research topics were: pathophysiology, symptoms, treatment, and epidemiology. The causes of long COVID may be related to organ injury, inflammation, maladaptation of the angiotensin-converting enzyme 2 (ACE2) pathway, and mental factors. The symptoms are varied, including physical and psychological symptoms. Treatment options vary from person to person. Most patients developed at least one long-term symptom. Finally, we presented some possible research opportunities.</description><identifier>ISSN: 1660-4601</identifier><identifier>ISSN: 1661-7827</identifier><identifier>EISSN: 1660-4601</identifier><identifier>DOI: 10.3390/ijerph19063742</identifier><identifier>PMID: 35329428</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>ACE2 ; Angiotensin ; Angiotensin-converting enzyme 2 ; Bibliometrics ; Citation indexes ; Clinical medicine ; Co authorship ; Cocitation ; Collaboration ; Complications ; Convalescence ; Cooperation ; Coronaviruses ; COVID-19 ; COVID-19 - complications ; COVID-19 - epidemiology ; Developed countries ; Environmental research ; Epidemiology ; Health care policy ; Humans ; Keywords ; Long COVID ; Medical research ; Medicine ; Pandemics ; Pathophysiology ; Peptidyl-dipeptidase A ; Primary care ; Public health ; Research methodology ; SARS-CoV-2 ; Severe acute respiratory syndrome coronavirus 2 ; Software</subject><ispartof>International journal of environmental research and public health, 2022-03, Vol.19 (6), p.3742</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-bcdd485c5e72295c7d6c2b88c1c20662822731b0891e97713f563c3cb84dc03</citedby><cites>FETCH-LOGICAL-c418t-bcdd485c5e72295c7d6c2b88c1c20662822731b0891e97713f563c3cb84dc03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955790/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8955790/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35329428$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jin, Hongxia</creatorcontrib><creatorcontrib>Lu, Lu</creatorcontrib><creatorcontrib>Fan, Haojun</creatorcontrib><title>Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis</title><title>International journal of environmental research and public health</title><addtitle>Int J Environ Res Public Health</addtitle><description>Long COVID is a condition distinguished by long-term sequelae that occur or persist after the convalescence period of COVID-19. During the COVID-19 pandemic, more and more people who tested positive for SARS-CoV-2 experienced long COVID, which attracted the attention of researchers. This study aims to assess the pattern of long COVID research literature, analyze the research topics, and provide insights on long COVID. In this study, we extracted 784 publications from Scopus in the field of long COVID. According to bibliometric analysis, it is found that: developed countries in Europe and America were in leading positions in terms of paper productivity and citations. The
and the
were leading journals in the perspective of publications count, and
had the highest number of citations. Author Greenhalgh T has the highest number of papers and citations. The main research topics were: pathophysiology, symptoms, treatment, and epidemiology. The causes of long COVID may be related to organ injury, inflammation, maladaptation of the angiotensin-converting enzyme 2 (ACE2) pathway, and mental factors. The symptoms are varied, including physical and psychological symptoms. Treatment options vary from person to person. Most patients developed at least one long-term symptom. Finally, we presented some possible research opportunities.</description><subject>ACE2</subject><subject>Angiotensin</subject><subject>Angiotensin-converting enzyme 2</subject><subject>Bibliometrics</subject><subject>Citation indexes</subject><subject>Clinical medicine</subject><subject>Co authorship</subject><subject>Cocitation</subject><subject>Collaboration</subject><subject>Complications</subject><subject>Convalescence</subject><subject>Cooperation</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - complications</subject><subject>COVID-19 - epidemiology</subject><subject>Developed countries</subject><subject>Environmental research</subject><subject>Epidemiology</subject><subject>Health care policy</subject><subject>Humans</subject><subject>Keywords</subject><subject>Long COVID</subject><subject>Medical research</subject><subject>Medicine</subject><subject>Pandemics</subject><subject>Pathophysiology</subject><subject>Peptidyl-dipeptidase A</subject><subject>Primary care</subject><subject>Public health</subject><subject>Research methodology</subject><subject>SARS-CoV-2</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Software</subject><issn>1660-4601</issn><issn>1661-7827</issn><issn>1660-4601</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkc1LAzEQxYMotlavHiXgxctqvjfxINSqrVIoqHgN2WxqU7abmmyF_veutop6GGZgfvOYxwPgGKNzShW68HMXlzOskKA5Izugi4VAGRMI7_6aO-AgpTlCVDKh9kGHckoUI7ILHoZVKEwFn6OrywRNXcJHl5yJdgZHoUnLtqCv4TjUr3Awebm_uYR9eO2LyoeFa6K3sF-bap18OgR7U1Mld7TtPfB0d_s8GGXjyfB-0B9nlmHZZIUtSya55S4nRHGbl8KSQkqLLUFCEElITnGBpMJO5TmmUy6opbaQrLSI9sDVRnW5KhautK5uoqn0MvqFiWsdjNd_N7Wf6dfwrqXiPFefAmdbgRjeVi41euGTdVVlahdWSRPBGMJEUNWip__QeVjF1u4XRRjnQrKWOt9QNoaUopv-PIOR_gxJ_w2pPTj5beEH_06FfgCSbYza</recordid><startdate>20220321</startdate><enddate>20220321</enddate><creator>Jin, Hongxia</creator><creator>Lu, Lu</creator><creator>Fan, Haojun</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PIMPY</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220321</creationdate><title>Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis</title><author>Jin, Hongxia ; Lu, Lu ; Fan, Haojun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-bcdd485c5e72295c7d6c2b88c1c20662822731b0891e97713f563c3cb84dc03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>ACE2</topic><topic>Angiotensin</topic><topic>Angiotensin-converting enzyme 2</topic><topic>Bibliometrics</topic><topic>Citation indexes</topic><topic>Clinical medicine</topic><topic>Co authorship</topic><topic>Cocitation</topic><topic>Collaboration</topic><topic>Complications</topic><topic>Convalescence</topic><topic>Cooperation</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - complications</topic><topic>COVID-19 - epidemiology</topic><topic>Developed countries</topic><topic>Environmental research</topic><topic>Epidemiology</topic><topic>Health care policy</topic><topic>Humans</topic><topic>Keywords</topic><topic>Long COVID</topic><topic>Medical research</topic><topic>Medicine</topic><topic>Pandemics</topic><topic>Pathophysiology</topic><topic>Peptidyl-dipeptidase A</topic><topic>Primary care</topic><topic>Public health</topic><topic>Research methodology</topic><topic>SARS-CoV-2</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jin, Hongxia</creatorcontrib><creatorcontrib>Lu, Lu</creatorcontrib><creatorcontrib>Fan, Haojun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of environmental research and public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jin, Hongxia</au><au>Lu, Lu</au><au>Fan, Haojun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis</atitle><jtitle>International journal of environmental research and public health</jtitle><addtitle>Int J Environ Res Public Health</addtitle><date>2022-03-21</date><risdate>2022</risdate><volume>19</volume><issue>6</issue><spage>3742</spage><pages>3742-</pages><issn>1660-4601</issn><issn>1661-7827</issn><eissn>1660-4601</eissn><abstract>Long COVID is a condition distinguished by long-term sequelae that occur or persist after the convalescence period of COVID-19. During the COVID-19 pandemic, more and more people who tested positive for SARS-CoV-2 experienced long COVID, which attracted the attention of researchers. This study aims to assess the pattern of long COVID research literature, analyze the research topics, and provide insights on long COVID. In this study, we extracted 784 publications from Scopus in the field of long COVID. According to bibliometric analysis, it is found that: developed countries in Europe and America were in leading positions in terms of paper productivity and citations. The
and the
were leading journals in the perspective of publications count, and
had the highest number of citations. Author Greenhalgh T has the highest number of papers and citations. The main research topics were: pathophysiology, symptoms, treatment, and epidemiology. The causes of long COVID may be related to organ injury, inflammation, maladaptation of the angiotensin-converting enzyme 2 (ACE2) pathway, and mental factors. The symptoms are varied, including physical and psychological symptoms. Treatment options vary from person to person. Most patients developed at least one long-term symptom. Finally, we presented some possible research opportunities.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35329428</pmid><doi>10.3390/ijerph19063742</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1660-4601 |
ispartof | International journal of environmental research and public health, 2022-03, Vol.19 (6), p.3742 |
issn | 1660-4601 1661-7827 1660-4601 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8955790 |
source | MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; PubMed Central Open Access |
subjects | ACE2 Angiotensin Angiotensin-converting enzyme 2 Bibliometrics Citation indexes Clinical medicine Co authorship Cocitation Collaboration Complications Convalescence Cooperation Coronaviruses COVID-19 COVID-19 - complications COVID-19 - epidemiology Developed countries Environmental research Epidemiology Health care policy Humans Keywords Long COVID Medical research Medicine Pandemics Pathophysiology Peptidyl-dipeptidase A Primary care Public health Research methodology SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Software |
title | Global Trends and Research Hotspots in Long COVID: A Bibliometric Analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-18T23%3A12%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Global%20Trends%20and%20Research%20Hotspots%20in%20Long%20COVID:%20A%20Bibliometric%20Analysis&rft.jtitle=International%20journal%20of%20environmental%20research%20and%20public%20health&rft.au=Jin,%20Hongxia&rft.date=2022-03-21&rft.volume=19&rft.issue=6&rft.spage=3742&rft.pages=3742-&rft.issn=1660-4601&rft.eissn=1660-4601&rft_id=info:doi/10.3390/ijerph19063742&rft_dat=%3Cproquest_pubme%3E2644012639%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2642455684&rft_id=info:pmid/35329428&rfr_iscdi=true |